Stockscreener 앱 받기
422.90
0.25%
-1.06
전일 마감가:
$423.96
열려 있는:
$423
하루 거래량:
105.69K
Relative Volume:
0.06
시가총액:
$149.40B
수익:
$11.03B
순이익/손실:
$3.16B
주가수익비율:
48.47
EPS:
8.7251
순현금흐름:
$3.22B
1주 성능:
+4.04%
1개월 성능:
+14.56%
6개월 성능:
-6.15%
1년 성능:
-1.56%
1일 변동 폭
$421.61
$425.88
1주일 범위
$402.00
$427.53
52주 변동 폭
$328.57
$603.88
인튜이티브 서지컬 Stock (ISRG) Company Profile
명칭
Intuitive Surgical Inc
전화
(408) 523-2100
주소
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, RMD, MDLN, ALC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
422.90 | 149.40B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
185.51 | 50.53B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
230.83 | 32.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.83 | 31.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.05 | 30.96B | 10.63B | 819.00M | 1.59B | 1.6577 |
인튜이티브 서지컬 Stock (ISRG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-07 | 개시 | Barclays | Overweight |
| 2026-08-12 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2026-07-30 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2026-07-28 | 개시 | UBS | Buy |
| 2026-07-09 | 개시 | BMO Capital Markets | Outperform |
| 2026-03-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-07-23 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-06-09 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2025-06-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | 재확인 | Citigroup | Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-11-17 | 개시 | HSBC Securities | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-19 | 재확인 | BTIG Research | Buy |
| 2023-04-19 | 재확인 | BofA Securities | Buy |
| 2023-04-19 | 재확인 | Citigroup | Buy |
| 2023-04-19 | 재확인 | Evercore ISI | In-line |
| 2023-04-19 | 재확인 | JP Morgan | Overweight |
| 2023-04-19 | 재확인 | Morgan Stanley | Equal-Weight |
| 2023-04-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-04-19 | 재확인 | Raymond James | Outperform |
| 2023-04-19 | 재확인 | Stifel | Buy |
| 2023-04-19 | 재확인 | Truist | Buy |
| 2023-04-19 | 재확인 | Wells Fargo | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-23 | 개시 | William Blair | Outperform |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-13 | 개시 | Mizuho | Neutral |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-25 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | 다운그레이드 | Redburn | Buy → Neutral |
| 2022-01-21 | 재확인 | BTIG Research | Buy |
| 2022-01-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-21 | 재확인 | Deutsche Bank | Hold |
| 2022-01-21 | 재확인 | Evercore ISI | In-line |
| 2022-01-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-01-21 | 재확인 | Piper Sandler | Neutral |
| 2022-01-21 | 재확인 | Raymond James | Outperform |
| 2022-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2022-01-21 | 재확인 | Stifel | Buy |
| 2022-01-21 | 재확인 | UBS | Neutral |
| 2022-01-21 | 재확인 | Wells Fargo | Overweight |
| 2022-01-10 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-07-21 | 재확인 | BofA Securities | Neutral |
| 2021-07-21 | 재확인 | Citigroup | Buy |
| 2021-07-21 | 재확인 | JP Morgan | Overweight |
| 2021-07-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-07-21 | 재확인 | Piper Sandler | Neutral |
| 2021-07-21 | 재확인 | SVB Leerink | Mkt Perform |
| 2021-07-21 | 재확인 | Stifel | Buy |
| 2021-07-21 | 재확인 | UBS | Neutral |
| 2021-07-21 | 재확인 | Wells Fargo | Overweight |
| 2021-07-14 | 재확인 | Goldman | Buy |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-04-21 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2021-04-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2020-12-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | 개시 | Argus | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-07-20 | 재확인 | Bernstein | Outperform |
| 2020-04-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | 다운그레이드 | CFRA | Hold → Sell |
| 2020-04-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-04-01 | 다운그레이드 | Oppenheimer | Perform → Underperform |
| 2020-01-27 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-12-12 | 재확인 | Wells Fargo | Outperform |
| 2019-11-21 | 개시 | Oppenheimer | Perform |
| 2019-07-19 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-22 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-02 | 개시 | Deutsche Bank | Buy |
| 2018-10-31 | 재확인 | Piper Jaffray | Overweight |
| 2018-10-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
모두보기
인튜이티브 서지컬 주식(ISRG)의 최신 뉴스
Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider - Zacks Investment Research
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect - The Motley Fool
Intuitive Surgical Inc. Advanced Charts | ISRG - Barron's
Intuitive Surgical (NASDAQ:ISRG) Combines Strong Growth With a Constructive Technical Setup - ChartMill
Should Barclays’ Bullish Initiation Amid Rising Rivalry Require Action From Intuitive Surgical (ISRG) Investors? - Yahoo! Finance Canada
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know - Zacks Investment Research
Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise? - Zacks Investment Research
Jim Cramer Has Soured on Intuitive Surgical (ISRG). The Reason is Johnson & Johnson - Yahoo Finance
Intuitive Surgical (XBUL:IUI1) 5-Year RORE % : 0.00% (As of Jun. 2026) - GuruFocus
Intuitive Surgical Inc. Research & Ratings | ISRG - Barron's
Intuitive Surgical: The Multiple Fell, The Story Didn't (NASDAQ:ISRG) - Seeking Alpha
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - Zacks Investment Research
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - TradingView
A Look at Intuitive Surgical Inc (ISRG) After 3.8% Gain -- GF Va - GuruFocus
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical Inc. Stock Grades | ISRG - Barron's
Intuitive Surgical Inc Stock (ISRG) Moved Up by 3.02% on Oct 5: Key Drivers Unveiled - TradingKey
What Do Fresh European Clearances Mean for Intuitive Surgical (NASDAQ:ISRG)? - Kalkine Media
Intuitive Surgical Inc. Research & Ratings | ISRG - Barron's
Intuitive Surgical: A Surgical Leader Facing A Valuation Problem (NASDAQ:ISRG) - Seeking Alpha
Intuitive Surgical (ISRG): Is Its Robotic-Surgery Moat Still Untouchable? - Yahoo Finance
Intuitive Surgical Inc. stock underperforms Friday when compared to competitors - marketwatch.com
Intuitive Surgical: The 17% Selloff Is A Buy (NASDAQ:ISRG) - Seeking Alpha
Can ISRG Offset China Weakness With Expansion in India and Japan? - Zacks Investment Research
Intuitive Surgical: Strong Growth, But Valuation Comes At A Premium - Seeking Alpha
Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors - marketwatch.com
Is Wall Street Dead Wrong About Intuitive Surgical? Here's My Honest Answer. - Yahoo Finance
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors - marketwatch.com
10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises - Zacks Investment Research
Top Stock Reports for Visa, Intuitive Surgical & Williams Companies - Zacks Investment Research
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Zacks Investment Research
Intuitive Surgical stock trades at EUR 364.65 before October 20 results - AD HOC NEWS
Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? - Yahoo Finance
Intuitive Surgical stock last trades at USD 414.55 on September 28, 2026 - AD HOC NEWS
Intuitive Surgical, Inc. (ISRG) Options ChainYahoo Finance - Yahoo! Finance Canada
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's How Much $1000 Invested In Intuitive Surgical 10 Years Ago Would Be Worth Today - Benzinga
Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting? - Yahoo Finance
Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting? - The Globe and Mail
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - Zacks Investment Research
Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx - Zacks Investment Research
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Zacks Investment Research
Sunnyvale tech firm accused of axing worker for reporting sexual harassment - The Mercury News
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - TradingView
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now - Yahoo Finance UK
2 Beaten-Down Stocks to Buy Before They Bounce Back - The Motley Fool
Why Intuitive Surgical (ISRG) Is Up 6.5% After New da Vinci SP Transvaginal Approval – And What's Next - Yahoo Finance
Intuitive Surgical stock heads into the open after a 2.3 percent fall - AD HOC NEWS
인튜이티브 서지컬 (ISRG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
인튜이티브 서지컬 주식 (ISRG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Widman Fredrik | VP Corporate Controller |
Sep 15 '26 |
Sale |
374.44 |
1,089 |
407,765 |
1,026 |
| FREDRIK WIDMAN | Officer |
Sep 15 '26 |
Proposed Sale |
377.94 |
2,178 |
823,153 |
0 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Sep 11 '26 |
Sale |
365.79 |
25 |
9,145 |
764 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Sep 10 '26 |
Sale |
347.66 |
23 |
7,996 |
789 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Sep 09 '26 |
Sale |
350.20 |
23 |
8,055 |
812 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Sep 08 '26 |
Sale |
361.23 |
46 |
16,617 |
835 |
| MARK BROSIUS | Officer |
Sep 08 '26 |
Proposed Sale |
366.70 |
694 |
254,490 |
0 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Aug 21 '26 |
Sale |
375.57 |
77 |
28,919 |
881 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Aug 20 '26 |
Sale |
396.37 |
77 |
30,520 |
958 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Aug 19 '26 |
Sale |
394.26 |
77 |
30,358 |
1,035 |
0.81%
0.83%
자본화:
|
볼륨(24시간):